Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a single-center prospective cohort study of clinical application of continuously monitored data by wearable activity trackers in the patients with thyrotoxicosis. The purpose of the study is to evaluate the association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status along with the treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biosignals by Wearable Devices in Hypothyroidism

NCT04332770

Hypothyroidism

COMPLETED

Heart Rate Monitoring by Wearable Devices in Graves' Disease

NCT04333342

Graves' Disease in Remission (Disorder)

UNKNOWN NA

Biosignals by Wearables in Thyroid Dysfunction

NCT04806269

Thyrotoxicosis Hypothyroidism

UNKNOWN

Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism

NCT04932135

Hyperthyroidism Graves Disease

COMPLETED

Clinical Feasibility of Disease Managing Mobile App for Hyperthyroidism

NCT05828732

Hyperthyroidism

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Activity trackers to be used: Fitbit Charge HR (TM)

Data which ware provided by Fitbit app (TM) will be analyzed in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyrotoxicosis Graves Disease Thyroiditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

thyrotoxicosis

patients with newly detected or recurrent thyrotoxicosis

No interventions assigned to this group

control

euthyroid, healthy adults

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing newly developed or recurrent thyrotoxicosis who are treated and followed-up in Seoul National University Bundang Hospital
* Patients who can use wearable activity trackers and smartphone applications
* In case of Graves' disease, patients who will treated by anti-thyroid drugs

Exclusion Criteria

* Patients who have thyrotoxic periodic paralysis
* In case of Graves' disease, patients who will treated by radioactive iodine therapy or thyroidectomy
* Patients who have thyrotoxicosis due to toxic nodular disease

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No